50-103-40

CD38 Monoclonal Antibody (HB7), PE, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-103-40-Each-of-1 In Stock ₹ 23,229.00

50-103-40 - Each of 1

₹ 23,229.00

In Stock

Quantity

1

Base Price: ₹ 23,229.00

GST (18%): ₹ 4,181.22

Total Price: ₹ 27,410.22

Antigen

CD38

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.1% gelatin, 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

P28907

Gene Symbols

CD38

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

952

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

HB7

Conjugate

PE

Gene

CD38

Gene Alias

T10, ADP-ribosyl cyclase 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase, CD38 antigen p45, NAD+ nucleosidase, cADPr hydrolase 1, cyclic ADP-ribose hydrolase 2

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

50-101-52

--

Img

Invitrogen

50-101-68

--

Img

Invitrogen

50-112-20

--

Img

Invitrogen

50-108-73

--

Img

Invitrogen

50-112-16

--

Img

Invitrogen

50-112-3295

--

Img

Invitrogen

50-112-2214

--

Img

Invitrogen

48-580-642

--

Description

  • Description: The HB7 monoclonal antibody reacts with the human CD38 molecule, an approximately 45 kDa type II transmembrane protein
  • CD38 is an ectoenzyme which catalyses NAD into nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP-ribose (cADPR), both of which are secondary messengers
  • Expression of CD38 is bimodal during B cell development, modulating from high in immature cells to low in intermediate ones and back to high on mature B cells
  • Additionally CD38 is found in a variety of tissues and other hematopoietic cells (e.g
  • T cells, NK cells and monocytes) and can be used to phenotype leukemias and monitor HIV-1 progression
  • The CD34+CD38- population of hematopoietic stems cells is thought to define the most pluripotent cells (e.g
  • blast colony forming cells)
  • In addition to surface expression, CD38 has recently been found in the nucleus where it may play a role in monitoring calcium levels
  • Applications Reported: This HB7 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This HB7 antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells
  • This can be used at 5 µL (0.06 µg) per test
  • A test is defined as the amount (µg) of antibody that will stain a cell sample in a final volume of 100 µL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • Excitation: 488-561 nm; Emission: 578 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • CD38 (NAD+ glycohydrolase) is a type II transmembrane glycoprotein able to induce activation, proliferation and differentiation of mature lymphocytes and mediate apoptosis of myeloid and lymphoid progenitor cells
  • CD38 functions as a multi-catalytic ectoenzyme serving as ADP-ribosyl cyclase, cyclic ADP-ribose hydrolase and possibly NAD+ glycohydrolase or as a cell surface receptor
  • Antibodies to CD38 are useful in subtyping of lymphomas and leukemias, detection of plasma cells (i.e
  • identification of myelomas), and as a marker for activated B and T cells
  • CD38 participates in cell adhesion, signal transduction and calcium signaling
  • Further, CD38 is expressed at high levels in the pancreas, liver, kidney, maligt lymphoma and neuroblastoma
  • Diseases associated with CD38 dysfunction include chronic lymphocytic leukemia and Richter’s Syndrome.